FAQ on NextPlat Corp's Q1 2025 Financial Performance and Business Expansion
Summary
NextPlat Corp reported a Q1 2025 revenue of $14.5 million, a decrease from the previous year, amidst healthcare challenges, while expanding its e-Commerce and airtime business, focusing on high-margin services and strategic healthcare growth.
What was NextPlat Corp’s revenue in Q1 2025?
NextPlat Corp reported a Q1 2025 revenue of $14.5 million, down from $17.5 million in the prior year.
Why did NextPlat Corp’s revenue decrease in Q1 2025?
The revenue decrease was driven by changes in 340B pharmacy agreements and prescription volume.
How did NextPlat Corp’s gross margin and operating expenses change in Q1 2025?
Gross margin declined to 23.8%, while operating expenses fell 26% to $4.9 million due to reduced legal and non-recurring costs.
What was NextPlat Corp’s net loss in Q1 2025?
The net loss narrowed to $1.3 million, or ($0.05) per share.
How much cash did NextPlat Corp have at the end of Q1 2025?
The company ended the quarter with $17.7 million in cash.
What areas of business did NextPlat Corp expand in Q1 2025?
NextPlat Corp expanded its e-Commerce reach, including a 51% increase in recurring airtime revenue and growing OPKO product sales in China.
What is NextPlat Corp’s focus moving forward?
Management remains focused on high-margin services and strategic healthcare growth.
Where can I find more information about NextPlat Corp?
More information is available in the company’s newsroom at https://ibn.fm/NXPL.
What does NextPlat Corp do?
NextPlat is a global e-commerce platform company focusing on technology and healthcare, offering e-commerce communications and healthcare data management services.
Where does NextPlat Corp operate?
NextPlat operates an e-commerce communications division worldwide and pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care Inc.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 113142